Table 1.
Baseline Characteristics of the Study Participants
| Parameter | ADT Group, Median [IQR] (n = 34) | Control Group, Median [IQR] (n = 29) | P Value |
|---|---|---|---|
| Age, y | 67.6 [64.6–72.0] | 70.6 [65.3–72.9] | 0.48 |
| Weight, kg | 83.6 [72.2–96.2] | 83.1 [76.3–91.4] | 0.95 |
| BMI, kg/m2 | 27.8 [25.4–31.5] | 27.2 [26.0–31.8] | 0.75 |
| Waist circumference, cm | 102 [96–111] | 100 [96–108] | 0.38 |
| Leptin, ng/ml | 6.74 [4.62–11.7] | 7.01 [4.62–11.1] | 0.99 |
| TSH, mIU/L | 1.69 [1.17–2.23] | 1.55 [1.42–2.15] | 0.66 |
| FT4, pmol/L | 12.0 [10.8–13.2] | 15.2 [13.4–16.5] | <0.001 |
| FT3, pmol/L | 4.90 [4.70–5.20] | 4.90 [4.50–5.10] | 0.66 |
| Testosterone, nmol/L | 14.1 [10.2–17.6] | 15.0 [11.1–16.9] | 0.91 |
| SHBG, nmol/L | 50.0 [41.0–62.0] | 44.0 [33.0–49.0] | 0.046 |
| Estradiol, pmol/L | 105 [73–143] | 86 [76–104] | 0.07 |
| Medical comorbidities, % | |||
| Ischemic heart disease | 17.6 | 17.2 | 1.00 |
| Diabetes mellitus | 14.7 | 17.2 | 1.00 |
| Liver disease | 0 | 0 | 1.00 |
| Chronic kidney disease | 0 | 0 | 1.00 |
| Hypertension | 58.8 | 58.6 | 1.00 |
Abbreviation: IQR, interquartile range.